Stem Cell Club Meeting


Stem Cell Club Meeting
Friday, March 23
Noon in 154 BSRB

615 Charles E. Young Drive South

Our speakers will be from Bill Lowry’s lab:

Michaela Patterson - “Defining and manipulating the developmental maturity of pluripotent stem cell derivatives”

Peiyee Lee - “Ataxia Telangiectasia - human disease modeling in a dish”

Lunch will be provided.

BSCRC and MIMG Seminar featuring Dr. Lili Yang


BSCRC - MIMG Seminar
Wednesday, March 21, 2012
10 - 11 AM
CHS 13-105

Lili Yang, PhD
California Institute of Technology

“Engineering Immunity Against Cancer and HIV/AIDS: From Hematopoietic Stem Cell Programming to MicroRNA Regulation”

Light Refreshments Served

Contact: Michelle Kim,

Stem Cell Scientists Discover a Way to Correct Mutations in Human Mitochondria by RNA Targeting

Researchers at the UCLA stem cell center and the departments of chemistry and biochemistry and pathology and laboratory medicine have identified, for the first time, a generic way to correct mutations in human mitochondrial DNA by targeting corrective RNAs, a finding with implications for treating a host of mitochondrial diseases.

Study Reveals Crucial Cell and Signaling Pathway that Regulate the Placental Hematopoietic Niche

UCLA stem cell researchers have discovered a critical placental niche cell and signaling pathway that prevent blood precursors from premature differentiation in the placenta, a process necessary for ensuring proper blood supply for an individual’s lifetime.

BSCRC Receives $1 Million Gift to Support Annual Educational Symposium

The Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research at UCLA received a $1 million gift today that will support a popular annual stem cell symposium on the Westwood campus that draws top scientists from around the world.

The Bloomfield Family Foundation, headed by Margaret “Peggy” Bloomfield of Pacific Palisades, made the gift. Bloomfield is a long-time supporter of the Broad Stem Cell Research Center.

BSCRC and JCCC Seminar Featuring Dr. Jonathan Slack


Thursday, March 1, 2012
Time: Noon - 1PM
Room: CNSI Auditorium

Jonathan M.W. Slack, Ph.D., F.Med.Sci.
Director, Stem Cell Institute
University of Minnesota

Talk Title: “Direct Reprogramming to Beta Cells?”

Co-sponsored by
Jonsson Comprehensive Cancer Center
Eli & Edythe Broad Center of Regenerative Medicine & Stem Cell Research

Light Lunch Served

BSCRC Scientists Explain Neural Cell Breakthrough

In a specially designed facility that is compliant with FDA Good Manufacturing Practices (GMP) requirements, scientists with the Eli and Edythe Center of Regenerative Medicine and Stem Cell Research at UCLA have taken human skin cells, reprogrammed them to be pluripotent and then differentiated them into neurons, using animal origin-free reagents and feeder conditions throughout the process.

UCLA Scientists Find Older, Established Human Embryonic Stem Cell Lines Are Not the Same as Newly Derived Cell Lines

Established human embryonic cell lines, including those approved for federal research funding under former President George W. Bush, are different than newly derived human embryonic stem cell lines, according to a study by UCLA stem cell researchers.

President Obama Nominates Broad Stem Cell Research Center Director Dr. Owen Witte to Serve on the President's Cancer Panel

Dr. Owen Witte, founding director of the Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research at UCLA and a renowned cancer researcher, was selected today by President Barack Obama to serve on the President’s Cancer Panel, which monitors the development and execution of the National Cancer Program.

The members of the panel are selected based on their training, experience and background as exceptionally qualified to appraise the National Cancer Program.

UCLA Scientists Prove that Blood Stem Cells can be Engineered to Produce T-Cells that Seek Out and Attack Melanoma

Researchers from UCLA’s stem cell and cancer centers have demonstrated for the first time that blood stem cells can be engineered to create cancer-killing T-cells that seek out and attack a human melanoma. The researchers believe this approach could be useful in 40 percent of Caucasians with this malignancy.